vTv Therapeutics Inc. (VTVT)
$28.23-7.32%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $74M
- Beta
- 0.28
- P/E (TTM)
- -256.64
- Short % float
- 11.09%
- Days to cover
- 3.3
- SI change
- -2.2%
- 1W
- -5.99%
- 1M
- -10.21%
- vs SPY 1W
- -5.86%
- vs SPY 1M
- -12.72%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VTVT?
- LOPJLB’s latest quantitative signal on vTv Therapeutics Inc. (VTVT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VTVT in?
- vTv Therapeutics Inc. (VTVT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does vTv Therapeutics Inc. (VTVT) do?
- vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodies…